These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33034138)

  • 1. High urinary glucose is associated with improved renal prognosis in patients with diabetes mellitus.
    Itano Y; Sobajima H; Ohashi N; Shibata T; Fujiya A; Nagata T; Ando M; Imaizumi T; Kubo Y; Ozeki T; Katsuno T; Kato S; Yasuda Y; Maruyama S
    J Diabetes Investig; 2021 Jun; 12(6):998-1006. PubMed ID: 33034138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K; Imamura M; Yamaguchi S; Teshigawara S; Tone A; Uchida HA; Eguchi J; Nakatsuka A; Ogawa D; Yoshida M; Yamada M; Shikata K; Wada J
    Diabetes Care; 2018 Aug; 41(8):1765-1775. PubMed ID: 29930140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus.
    Monobe K; Noso S; Babaya N; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Minohara T; Kawabata Y; Ikegami H
    J Diabetes Investig; 2021 May; 12(5):728-737. PubMed ID: 32986906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang KKL; Tang WE; Kwan PY; Tavintharan S; Sum CF; Lim SC
    Diab Vasc Dis Res; 2018 Sep; 15(5):417-423. PubMed ID: 29807475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models.
    Kobayashi K; Toyoda M; Hatori N; Furuki T; Sakai H; Umezono T; Ito S; Suzuki D; Takeda H; Minagawa F; Degawa H; Yamamoto H; Machimura H; Chin K; Hishiki T; Takihata M; Aoyama K; Umezawa S; Minamisawa K; Aoyama T; Hamada Y; Suzuki Y; Hayashi M; Hatori Y; Sato K; Miyakawa M; Tamura K; Kanamori A
    J Diabetes Investig; 2021 Jan; 12(1):74-81. PubMed ID: 32506833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitor-induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score-matched model analysis in Japan.
    Kobayashi K; Toyoda M; Hatori N; Furuki T; Sakai H; Sato K; Miyakawa M; Tamura K; Kanamori A
    J Diabetes Investig; 2021 Aug; 12(8):1408-1416. PubMed ID: 33377605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal glucose handling: impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes.
    Ferrannini E; Veltkamp SA; Smulders RA; Kadokura T
    Diabetes Care; 2013 May; 36(5):1260-5. PubMed ID: 23359360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes.
    Sullivan KM; Scholey J; Moineddin R; Sochett E; Wicklow B; Elia Y; Xiao F; Mederios T; Sadi P; Burger D; Mahmud FH; Dart AB
    Diabetologia; 2021 Feb; 64(2):469-475. PubMed ID: 33037887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients.
    Carpentier C; Dubois S; Mohammedi K; Belhatem N; Bouhanick B; Rohmer V; Briet C; Bumbu A; Hadjadj S; Roussel R; Potier L; Velho G; Marre M
    Nephrol Dial Transplant; 2019 Oct; 34(10):1731-1738. PubMed ID: 29982607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of blood glucose and renal end points in advanced diabetic kidney disease.
    Kornelius E; Lo SC; Huang CN; Wang YH; Yang YS
    Diabetes Res Clin Pract; 2020 Mar; 161():108011. PubMed ID: 31991151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.
    Matar O; Potier L; Abouleka Y; Hallot-Feron M; Fumeron F; Mohammedi K; Hadjadj S; Roussel R; Velho G; Marre M
    Diabetes Metab; 2020 Nov; 46(6):488-495. PubMed ID: 32259661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
    Hirowatari K; Kawano N
    Int Urol Nephrol; 2023 Aug; 55(8):2111-2118. PubMed ID: 36840803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.
    Ono S; Ono Y; Koide D; Yasunaga H
    J Epidemiol; 2020 Aug; 30(8):326-331. PubMed ID: 31204363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
    Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
    Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between dipstick hematuria and decline in estimated glomerular filtration rate among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 14)].
    Mashitani T; Hayashino Y; Okamura S; Kitatani M; Furuya M; Iburi T; Tsujii S; Ishii H;
    J Diabetes Complications; 2017 Jul; 31(7):1079-1084. PubMed ID: 28499960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.